retatrutide injection pen Extreme Side Effects Followed Overdose of Unapproved Weight-Loss Drug Retatrutide Pen (30/40/60mg)

Ongoing Support & Check-Ins Monthly progress reviews and provider oversight to keep you on track

Results May Vary Individual results will vary based on factors including age, baseline weight, metabolic health, consistency of medication use, lifestyle factors (diet, physical activity, sleep), genetic factors, current medications, and other individual variables

Using smaller doses lowers these problems and makes the medication easier on the body

Poppi founder Allison Ellsworth shares favorite food, beauty and wellness finds [Modern Retail]

A 2022 clinical trial funded by Novo Nordisk (which makes Ozempic and Wegovy) found that a weekly dose of one GLP-1 drug reduced heavy-drinking days and total intake for people struggling with alcohol use disorder but only in a subgroup of patients with a BMI over 30